Cargando…

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors

Current treatments for type 2 diabetes (T2D) and obesity do not reliably achieve long-term weight-loss and up to 50% of patients experience nausea and vomiting. Thus, there is a critical need for obesity medications that provide glycemic control with enhanced hypophagic response without nausea/emesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chichura, Kylie, Elfers, Clinton, Salameh, Therese, Sweet, Ian, Roth, Christian, Doyle, Prof Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625289/
http://dx.doi.org/10.1210/jendso/bvac150.871

Ejemplares similares